Cell-surface-localized plant immune receptors, such as FLS2, detect pathogen-associated molecular patterns (PAMPs) and initiate PAMP-triggered immunity (PTI) through poorly understood signal-transduction pathways. The pathogenic Pseudomonas syringae effector AvrPphB, a cysteine protease, cleaves the Arabidopsis receptor-like cytoplasmic kinase PBS1 to trigger cytoplasmic immune receptor RPS5-specified effector-triggered immunity (ETI). Analyzing the function of AvrPphB in plants lacking RPS5, we find that AvrPphB can inhibit PTI by cleaving additional PBS1-like (PBL) kinases, including BIK1, PBL1, and PBL2. In unstimulated plants, BIK1 and PBL1 interact with FLS2 and are rapidly phosphorylated upon FLS2 activation by its ligand flg22. Genetic and molecular analyses indicate that BIK1, and possibly PBL1, PBL2, and PBS1, integrate immune signaling from multiple immune receptors. Whereas AvrPphB-mediated degradation of one of these kinases, PBS1, is monitored by RPS5 to initiate ETI, this pathogenic effector targets other PBL kinases for PTI inhibition.
INTRODUCTION
Plants use a suite of cell-surface-localized pattern-recognition receptors to detect various pathogen/microbe-associated molecular patterns (PAMPs/MAMPs) and trigger immune responses (Schwessinger and Zipfel, 2008) . PAMP-triggered immunity (PTI) is critical for the survival of land plants under constant threat from numerous potential pathogenic microbes. The signal-transduction mechanism underlying PTI, however, is not well understood. The best-studied PTI pathway is initiated by the receptor kinase FLS2. Upon binding to the bacterial flagellar peptide flg22 , FLS2 rapidly associates with another receptor-like kinase, BAK1, to activate defenses (Chinchilla et al., 2007; Heese et al., 2007) . Similarly, the receptor kinase EFR binds the bacterial elongation factor-Tu (EF-Tu) peptide elf18 to trigger immune responses (Zipfel et al., 2006) . Another receptor-like kinase, CERK1, is required for defenses in response to chitin, a fungal cell-wall component. CERK1 possesses three LysM domains that are thought to bind chitin (Miya et al., 2007; Wan et al., 2008) . CERK1 is also required for plant resistance to the bacterial pathogen Pseudomonas syringae (Gimenez-Ibanez et al., 2009) , although the corresponding PAMP remains to be identified. Downstream, two MAP kinase cascades are activated. MEKK1, MKK1, MKK2, and MPK4 constitute a cascade negatively regulating PTI defenses (Ichimura et al., 2006; Qiu et al., 2008; SuarezRodriguez et al., 2007) , whereas MPK3 and MPK6 are thought to positively regulate PTI defenses (Schwessinger and Zipfel, 2008) . We have no knowledge of additional components that act in early phases of the signal transduction. Furthermore, it is not known how signals from distinct immune receptors are integrated to activate an overlapping set of downstream defense responses.
P. syringae secretes a large number of effector proteins into host cells to assist its proliferation in plants (Cunnac et al., 2009 ). Many of these effector proteins are capable of targeting components of the PTI signaling pathway to suppress plant immunity (Block et al., 2008; Fu et al., 2007; Gimenez-Ibanez et al., 2009; Gö hre et al., 2008; Kim et al., 2005; Li et al., 2005; Nomura et al., 2006; Xiang et al., 2008; Zhang et al., 2007; Zhou and Chai, 2008) . For example, the P. syringae effector AvrPto acts as a kinase inhibitor to directly block immune signaling from FLS2 and EFR (Xiang et al., 2008) . Another P. syringae effector, AvrPtoB, structurally and functionally mimics E3 ubiquitin ligase Abramovitch et al., 2006) and inhibits PTI by targeting FLS2 (Gö hre et al., 2008) and CERK1 (Gimenez-Ibanez et al., 2009 ) for degradation. Shan et al. (2008) suggested that both AvrPto and AvrPtoB target BAK1. In addition, the P. syringae effector HopAI1 uses phosphothreonine lyase activity to ''dephosphorylate'' Arabidopsis MPK3 and MPK6, thereby permanently inactivating the MAP kinases . The fact that many of the P. syringae effectors target important signaling components to inhibit PTI suggests that they can be used as powerful molecular probes to identify PTI signaling components. Indeed, analyses of host targets for the P. syringae effectors HopU1 and HopM1 have led to the identification of GRP7 and MIN7 as mediators of plant immunity (Fu et al., 2007; Nomura et al., 2006) . Some pathogen effectors trigger immunity mediated by cytoplasmic immune receptors that are primarily nucleotide-binding, leucine-rich repeat (NB-LRR) proteins. The recognition of effectors by NB-LRR proteins is often indirectly mediated by other host proteins of diverse biochemical functions (Jones and Dangl, 2006) . For example, the recognition of AvrPto by the NB-LRR protein Prf in tomato plants is mediated by the protein kinase Pto (Mucyn et al., 2006; Tang et al., 1996) . Likewise, the P. syringae effector AvrPphB, a cysteine protease, triggers RPS5-specified disease resistance by proteolytically cleaving the cytoplasmic receptor-like kinase PBS1 (Ade et al., 2007; Shao et al., 2003) . Thus, the Prf-Pto and RPS5-PBS1 protein complexes act as a conformational switch that is activated only when the corresponding effector proteins are present. However, it is not understood why different host proteins are deployed as sensors for effector-triggered immunity (ETI).
Here we show that AvrPphB inhibits PTI when directly expressed in plants. Interestingly, AvrPphB is capable of proteolytically cleaving a number of PBS1-like (PBL) proteins belonging to the subfamily VII of cytoplasmic receptor-like protein kinases. One of the PBL proteins, BIK1, is required for signaling elicited by flg22, elf18, and chitin and is essential for PAMP-induced resistance to P. syringae. Other members including PBL1, PBL2, and PBS1 also contribute to PTI defenses. BIK1 interacts with FLS2, EFR, and CERK1 in unstimulated plants. Treatment of plants with flg22 induces BIK1 phosphorylation in an FLS2-and BAK1-dependent manner. These results indicate that these kinases, particularly BIK1, play a central role in signal integration from multiple surface-localized receptors.
RESULTS

Transgenic AvrPphB Inhibits PTI Signaling
We used a protoplast-based reporter assay (Li et al., 2005; Xiang et al., 2008) to determine whether flg22-induced expression of FRK1, a PTI marker gene, can be inhibited by the expression of the AvrPphB transgene. Flg22 induces the expression of FRK1 promoter-firefly luciferase reporter gene (FRK1::LUC; Figure 1A) . The presence of AvrPphB reduced FRK1::LUC expression by 80%, but the protease-compromised AvrPphB C98S mutant (cysteine 98 to serine; Shao et al., 2003) was largely unable to inhibit FRK1::LUC expression ( Figure 1A ; see Figure S1A available online) . To further determine whether AvrPphB possesses PTI-inhibitory activity, we introduced a FLAG-tagged AvrPphB transgene into the Arabidopsis rps5-2 mutant. Arabidopsis plants exposed to various PAMPs deposit callose at the cell wall and develop a rapid oxidative burst exemplified by the accumulation of H 2 O 2 Gó mez-Gó mez et al., 1999; Kunze et al., 2004; Miya et al., 2007) . The flg22-induced H 2 O 2 accumulation in T1 AvrPphB transgenic plants was reduced to 25% compared with the nontransgenic rps5 control ( Figure 1B) . Two independent transgenic lines in the T3 generation were further tested for oxidative burst and callose deposition in response to flg22, elf18, and chitin. H 2 O 2 accumulation in the two AvrPphB transgenic lines was consistently reduced to 20%-40% compared with nontransgenic rps5 control ( Figures 1C-1E) . Similarly, PAMP-induced callose deposition in AvrPphB transgenic plants was also reduced to 40%-50% compared with control plants ( Figure 1F ). Together, these results indicated that AvrPphB is capable of inhibiting signaling from all three PAMPs.
PBS1-like Kinases Are AvrPphB Substrates
The cleavage of PBS1 does not appear to account for the PTI-inhibition activity of AvrPphB, because our initial analysis of pbs1 mutants showed only minimal defects in PTI defenses. As expected, an immunoblot experiment did not detect a cleavage or reduction in abundance of FLS2 in AvrPphB transgenic plants ( Figure S1B ). We therefore hypothesized that AvrPphB may target additional host proteins homologous to PBS1 for PTI inhibition. PBS1 belongs to receptor-like cytoplasmic kinase (RLCK) subfamily VII. The amino acid sequences of the 45 RLCK VII members were therefore aligned and analyzed for the AvrPphB recognition sequence ( Figure S2A ). In total, we identified 29 putative PBL proteins as potential substrates for AvrPphB. One of the PBL proteins is BIK1, an RLCK required for resistance to Botrytis cinerea (Veronese et al., 2006) . The remaining PBL proteins are named PBL1-PBL28. The putative AvrPphB substrates were fused to an HA tag and transiently expressed in Arabidopsis rps5 mutant protoplasts along with AvrPphB. The coexpression of AvrPphB resulted in cleavage of nine of the ten selected proteins (Figure 2A) . PBL6, which contains a D-to-S substitution in the GDK motif, was not cleaved. PBL1, which contains a D-to-E substitution in the GDK motif, was cleaved normally, suggesting that an acidic residue in the GDK motif is required for the cleavage. These results are consistent with a previous report that a D-to-A substitution in the GDK motif of PBS1 reduces AvrPphB cleavage by 75% (Shao et al., 2003) . BSK1, an RLCK XII family member involved in brassinosteroid signaling , was not cleaved by AvrPphB, indicating that AvrPphB specifically targets PBS1 and PBL proteins. The proteasecompromised AvrPphB mutant did not cleave BIK1 ( Figure S2B ). To determine whether the AvrPphB protein delivered from the P. syringae bacteria is capable of cleaving BIK1, we generated transgenic lines expressing HA-tagged BIK1 under the control of the BIK1 native promoter in the rps5 mutant background. Inoculation of BIK1::BIK1-HA plants with P. syringae carrying avrPphB produced a cleaved product, whereas the plants inoculated with the P. syringae strain lacking avrPphB did not ( Figure 2B ).
An examination of public microarray data indicated that BIK1, PBL1, and PBL2 transcripts are strongly upregulated by flg22. Quantitative RT-PCR confirmed this result with flg22 treatment inducing BIK1, PBL1, and PBL2 transcripts by 2.5-to 5.5-fold compared with an H 2 O-treated control ( Figure S3A ). A small but statistically significant induction of PBS1 by flg22 was also observed. These results suggest that the PBL genes are linked to PTI defenses. phosphatase completely restored normal migration to both BIK1 and PBL1, indicating that these proteins were phosphorylated after flg22 treatment. The phosphorylation is transient in nature because BIK1 migrated normally 20 min after flg22 treatment ( Figure 3B ). Flg22 failed to induce BIK1 phosphorylation in fls2 protoplasts ( Figure 3B ). Transfection of fls2 protoplasts with an FLS2-FLAG plasmid restored the flg22-induced BIK1 phosphorylation. Likewise, BIK1 was not phosphorylated in bak1 mutant protoplasts ( Figure 3C ), indicating that both FLS2 and BAK1 are required for the flg22-induced phosphorylation of BIK1. The flg22-induced, FLS2-dependent phosphorylation was also observed in stable BIK1::BIK1-HA transgenic plants ( Figure 3D ). Together, the results indicate that the activation of FLS2 by flg22 induces a transient phosphorylation of BIK1 and PBL1. We previously showed that AvrPto inhibits kinase activity of FLS2. Coexpression of WT AvrPto, but not AvrPto Y89D mutant, which does not interact with FLS2, prevented the flg22-induced phosphorylation of BIK1 ( Figure S3B ), suggesting that the kinase activity of FLS2 is required for BIK1 phosphorylation in the protoplasts.
Minutes after treatment
BIK1 Interacts with FLS2 and Dissociates from FLS2 following Flg22 Treatment
Because BIK1 is localized to the plasma membrane (Veronese et al., 2006) and phosphorylated rapidly in response to flg22, we asked whether BIK1 interacts with FLS2. A GST pull-down experiment showed that GST-BIK1, but not GST, interacted with the His-tagged FLS2 kinase domain in vitro ( Figure 4A ). Coimmunoprecipitation (co-IP) experiments in BIK1::BIK1-HA transgenic plants showed that BIK1 interacted with the endogenous FLS2 in plants ( Figure 4B ). We also coexpressed BIK1-HA with FLAG-tagged FLS2, EFR, BAK1, and CERK1 in Arabidopsis protoplasts and performed co-IP assays ( Figure S4 ). A strong interaction of BIK1 with FLS2, EFR, and CERK1, but not BAK1, was observed. We detected a weak signal of BAK1-BIK1 asso- We further used the protoplast transient expression system to determine the effect of flg22 treatment on BIK1-FLS2 interaction. Surprisingly, flg22 treatment significantly reduced BIK1-FLS2 interaction ( Figure 4C ). We similarly detected a strong interaction of FLS2 with PBS1, PBL1, and PBL2 in the absence of flg22 treatment. In each case, the addition of flg22 also significantly reduced the interaction of FLS2 with PBS1 and the PBL proteins. These results suggest that BIK1, PBS1, and the two PBL proteins are associated with FLS2 in unstimulated cells, and that the activation of FLS2 by flg22 induces the dissociation of the protein complex. The flg22-induced BIK1 phosphorylation is less pronounced in these experiments, likely because of the presence of unknown phosphatases during the co-IP experiments. The unstable BIK1 phosphorylation is also consistent with the transient nature of BIK1 phosphorylation.
The flg22-induced BIK1 phosphorylation and BIK1-FLS2 dissociation prompted us to determine whether these two events are linked. Because BAK1 is required for the phosphorylation of BIK1, we examined the flg22-induced BIK1-FLS2 dissociation in bak1 mutant protoplasts. Figure 4D shows that flg22 does not induce such dissociation in the bak1 mutant, indicating that BAK1 is required for the dissociation. We further examined the dissociation in the presence of AvrPto. Coexpression of AvrPto, but not AvrPto Y89D , prevented BIK1-FLS2 dissociation ( Figure 4E ). These results suggest that the flg22-induced phosphorylation of BIK1 is required for BIK1-FLS2 dissociation.
BIK1 and PBL1 Are Required for PAMP-Induced Defenses The results described above suggest that BIK1, PBS1, and PBL proteins act downstream of FLS2, EFR, and CERK1 to mediate PTI signaling. To determine the function of BIK1 and PBS1 in PTI defenses, we first examined PAMP-induced H 2 O 2 Cell Host & Microbe PBS1-like Kinases Regulate Plant Immunity production in loss-of-function bik1 (Veronese et al., 2006) and pbs1-2 mutants (Warren et al., 1999) . When treated with flg22, bik1 consistently accumulated 50%-80% less H 2 O 2 compared with WT, whereas the fls2 mutant was completely unable to respond to flg22 ( Figure 5A ; Figure S5A ). Similarly, elf18-and chitin-induced H 2 O 2 production was also reduced to 20%-40% compared with WT ( Figures 5B and 5C ). The pbs1 mutant frequently showed a minimal, but statistically significant, reduction in H 2 O 2 accumulation ( Figures 5A-5C ). We next determined whether the bik1 mutation affected PAMP-induced callose deposition at the cell wall. The bik1 mutant showed only approximately 25%-50% callose deposits compared with WT, whereas the fls2, efr, and cerk1 mutants had 10% or less callose deposits in response to the corresponding PAMPs ( Figure 5D ; Figures  S5B-S5D ). The pbs1 mutant again displayed a small but statistically significant reduction of callose deposition ( Figure 5D ).
Immunoblot analysis showed that FLS2 protein level was not affected by bik1 and pbs1 mutations ( Figure S5E ), indicating that the observed defects in PAMP signaling were not indirectly caused by instability of FLS2 in these mutants.
To determine whether PBL1 and PBL2 also play a role in PAMP-induced responses, we identified homozygous T-DNA insertion mutants pbl1 and pbl2 ( Figure S5F ). Unlike bik1, which is smaller in size than WT (Veronese et al., 2006) , the newly identified pbl mutants were morphologically normal ( Figure S5G ). As expected, the T-DNA insertion resulted in a near complete loss of PBL1 and PBL2 transcripts in pbl1 and pbl2 mutants, respectively ( Figure S5H ). These mutants were examined for PAMP-induced oxidative burst and callose deposition. pbl1 and pbl2 showed a small ($30%) but statistically significant reduction in flg22-induced H 2 O 2 production compared with WT ( Figure S5I ). elf18-induced H 2 O 2 production was reduced to $40% in pbl1 but was normal in the pbl2 mutant ( Figure S5J ). The chitin-induced H 2 O 2 production was largely normal in both pbl1 and pbl2 ( Figure S5K ). In addition, callose deposition in pbl1 was normal upon flg22 treatment, but was significantly reduced when treated with elf18 and chitin ( Figure S5L ). pbl2 showed significantly reduced callose deposition in flg22 and elf18 treatment, but was completely normal upon chitin treatment ( Figure S5L ). Taken together, these results indicate that BIK1 and, to a lesser extent, PBL1, PBL2, and PBS1, are required for PTI defenses. We next constructed a bik1/pbl1 double mutant. The flg22-induced oxidative burst and chitininduced callose deposition were further reduced in the double mutant compared with the single mutants ( Figures 5E and 5F ), indicating that BIK1 and PBL1 act additively in PTI defenses.
BIK1 Is Required for PAMP-Induced Resistance to P. syringae Bacteria A flg22-protection assay was carried out to determine whether BIK1 is required for PAMP-induced resistance to P. syringae . Pretreatment of WT and pbs1 plants with flg22 completely protected plants from subsequent infection by a virulent strain of P. syringae ( Figure 6A ). In contrast, flg22 pretreatment failed to enhance resistance to P. syringae in bik1 plants. In the absence of flg22 treatment, the bik1 mutant displayed elevated resistance to this strain (Veronese et al., 2006) , likely because of heightened salicylic acid (SA) level in the bik1 mutant, a phenotype that has also been reported for bak1/bkk1 mutants . Nonetheless, flg22-treated bik1 plants supported approximately 3-to 10-fold greater bacterial growth than did the flg22-treated WT plants. To further determine the role of BIK1 in PAMP-induced resistance to P. syringae, we spray inoculated WT and bik1 plants with a nonpathogenic mutant strain of P. syringae, hrcC À , which carries a collection of PAMPs but lacks a functional type III secretion system. Strikingly, the hrcC À mutant bacteria grew 100-fold greater in bik1 than in WT plants ( Figure 6B ). Similar experiments failed to detect altered bacterial growth in pbs1, pbl1, and pbl2 mutants (data not shown). These results indicate that BIK1 plays a major role in PAMP-induced resistance to P. syringae. It may be argued that the high level of SA in the bik1 mutant might have inhibited PTI defenses. However, this is highly unlikely because SA is known to positively regulate PTI defenses (Mishina and Zeier, 2007; Tsuda et al., 2008) . We nonetheless generated a bik1/sid2 double mutant to determine whether the defects of PTI defenses in bik1 were caused by elevated SA in this mutant. SID2 encodes an isochorismate synthase that is critical for the pathogen-induced SA accumulation in plants (Wildermuth et al., 2001) . Consistent with a positive role of SA in PTI defenses, the sid2 mutant displayed reduced H 2 O 2 production and callose deposition in response to flg22 ( Figures  S6A and S6B ). The bik1/sid2 double mutant was further compromised in these responses. Furthermore, bacterial growth assay showed that the bik1/sid2 double mutant was not protected by flg22 treatment, compared with the normal protection in sid2 and WT plants ( Figure S6C ). Taken together, these results demonstrated that BIK1 is required for PAMP-induced resistance to P. syringae that is likely independent of SA accumulation.
BIK1 Phosphorylation Positively Regulates PAMP Signaling
To determine the role of BIK1 kinase activity in PAMP signaling, we introduced a lysine 105-to-glutamate substitution (K105E) into BIK1 and overexpressed this mutant in protoplasts. K105 is a conserved ATP-binding site and the mutation is expected to abolish kinase activity. Figure S7A shows that whereas the expression of the WT BIK1 constitutively induced FRK1::LUC reporter gene expression, the BIK1 K105E mutation
LUC expression ( Figure 7A ; Figure S7A ), indicating that BIK1 K105E acted as a dominant-negative mutant in PTI signaling. Similarly, overexpression of the ATP-binding site mutant form of PBS1, PBL1, and PBL2 also inhibited PAMP-induced FRK1::LUC expression ( Figure 7A ). Interestingly, a BIK1 G230A/D231A mutant (BIK1 GD/AA ) in which the AvrPphB cleavage site was mutated also showed a dominant-negative effect when expressed in protoplasts, indicating that G230 and D231 are functionally important residues. Immunoblotting showed that these mutant proteins were expressed normally in protoplasts ( Figure S7B ). The FLAG-tagged WT BIK1 and BIK1 K105E mutant were introduced PTI signaling and indicate that the kinase activity of these proteins is required for function. Attempts to determine whether FLS2 directly phosphorylates BIK1 in vitro were unsuccessful, because recombinant FLS2 possessed only weak kinase activity. Nonetheless, the FLS2-and BAK1-dependent, flg22-induced phosphorylation of BIK1 prompted us to test the functional significance of BIK1 phosphorylation. Mass spectrometry analysis was carried out to determine phosphorylation sites in autophosphorylated BIK1. Because BIK1 is an RD kinase, which contains a conserved arginine immediately preceding the invariant aspartate in subdomain VI essential for catalytic activity, and the phosphorylation of the activation loop often is required for the activation of RD kinases (Nolen et al., 2004) , we inspected potential phosphorylation sites in the activation loop. Indeed, a phosphorylated S236 in the activation loop was readily detected ( Figure S7D ). Sitedirected mutagenesis was carried out to determine whether S236 is required for PAMP-induced FRK1::LUC expression. When expressed in protoplasts, BIK1
S236A acted as a dominant-negative mutant and strongly inhibited PAMP-induced FRK1::LUC expression ( Figure 7C ), indicating that S236 is important for signaling. We next determined whether S236 is required for flg22-induced phosphorylation of BIK1 in protoplasts. Whereas the majority of WT BIK1 becomes phosphorylated within 5 min of flg22 treatment, only a small proportion of BIK1 S236A is phosphorylated, indicating that S236 is required for optimum phosphorylation ( Figure 7D ). We reasoned that additional amino acids in the activation loop may be phosphorylated, and therefore constructed a quadruple mutant BIK1 SYST/AAAA carrying S233A, Y234A, S236A, and T237A substitutions. Indeed, no phosphorylation was detected in the BIK1 SYST/AAAA mutant ( Figure S7E ). Consistent with the possibility that additional residues in the activation loop are phosphorylated upon flg22 treatment, the BIK1 T237A mutant also acted as a dominant-negative mutant and inhibited PAMP-induced FRK1::LUC expression ( Figure 7C ).
BIK1-FLS2 Dissociation Is Not Required for FLS2-BAK1 Association
The dominant-negative effect of the BIK1 K105E mutant prompted us to determine whether the mutation affects BIK1-FLS2 interaction. Strikingly, the mutant showed stronger interaction with FLS2 in protoplasts ( Figure S4D ), and the flg22 treatment failed to induce its dissociation from FLS2. Our results in Figures 3 and 4 indicated that BAK1 is required for the flg22-induced phosphorylation of BIK1 and BIK1-FLS2 dissociation. We further explored the relationship between FLS2-BIK1 dissociation and FLS2-BAK1 association in protoplasts. The flg22 treatment induced a strong interaction between FLS2 and BAK1, as previously reported (Chinchilla et al., 2007; Heese et al., 2007) , and coexpression of either WT BIK1 or the BIK1 K105E mutant did not inhibit FLS2-BAK1 association ( Figure S4E ), suggesting that a BIK1-FLS2 dissociation is not a prerequisite for FLS2-BAK1 association.
DISCUSSION
In this study, we show that the P. syringae effector AvrPphB can target multiple PBS1-like kinases and inhibit PTI defenses. Genetic analyses showed that BIK1 and, to a lesser extent, PBL1, PBL2, and PBS1, are required for signaling from multiple PAMPs. Protein-protein interaction and phosphorylation studies suggested that BIK1, and likely PBS1 and other PBL proteins, directly act downstream of FLS2, EFR, and CERK1 to trigger immune responses. Thus, the PBL and PBS1 proteins are key components that integrate signaling from multiple immune receptors. Plants of the indicated genotypes were spray inoculated with P. syringae hrcC À mutant bacteria, and the bacterial population in the leaf was determined at the indicated times. Error bars indicate standard deviation. Student's t test was carried out to determine the significance of the difference of hrcC À mutant bacterial growth between WT and bik1 plants. ** indicates a significant difference at p < 0.01. The experiments were repeated four times with similar results.
In addition to PBS1, our analysis identified at least eight PBL proteins that are proteolytically cleaved by AvrPphB. A previous report suggested that recombinant AvrPphB specifically cleaves in vitro translated PBS1, but not its homologs (Shao et al., 2003) . Either the recombinant AvrPphB protein is not fully active or the in vitro translated PBS1 homologs are not optimum for cleavage. BIK1 is localized to the plasma membrane (Veronese et al., 2006) . PBS1 and many other PBL proteins may also localize to the plasma membrane, because these proteins possess putative myristoylation and palmitoylation sites at the N terminus ( Figure S2A ). Consistent with a role in targeting these kinases, AvrPphB is fatty acylated following autoproteolysis and localized to the plasma membrane (Dowen et al., 2009; Nimchuk et al., 2000) . When directly expressed in plants, AvrPphB inhibited defenses triggered by flg22, elf18, and chitin. This is consistent with our findings that bik1, pbl1, pbl2, and pbs1 mutants are compromised to varying degrees in defense responses induced by these PAMPs. Together, our results support that AvrPphB targets BIK1, and possibly PBS1 and other PBL proteins, to inhibit PTI.
It should be noted that AvrPphB is an effector from P. syringae pv phaseolicola, a nonadapted bacterium on Arabidopsis. Overexpression of AvrPphB in Arabidopsis protoplasts resulted in a significant but incomplete cleavage of BIK1. Delivery of AvrPphB from P. syringae bacteria only resulted in a cleavage of a small proportion of BIK1 in plants. These results explain the partial loss of PTI responses in stable AvrPphB transgenic plants and the inability to detect virulence activity on Arabidopsis plants when avrPphB is carried by the bacterium. One speculation is that a BIK1 ortholog in bean could be a better substrate for AvrPphB.
Our reverse genetic and molecular analyses demonstrate that BIK1 is an important component for integrating signaling from multiple PAMP receptors. The bik1 mutant is greatly compromised in PAMP-induced oxidative burst and callose deposition. Most importantly, the bik1 mutant is severely compromised in PAMP-induced resistance to P. syringae in flg22-protection assays and hrcC À mutant bacteria spray-inoculation assays. pbl1, pbl2, and pbs1 all exhibited small but statistically significant reduction in PTI defenses in response to one or more PAMPs, indicating that PBL1, PBL2, and PBS1 also contribute to PTI defense responses. Furthermore, a bik1/pbl1 double mutant displayed greater defects in PTI defenses than did single mutants, indicating that BIK1 and PBL1 act additively in PAMPinduced defense responses.
The bik1 mutant constitutively accumulates SA (Veronese et al., 2006) . However, the increased SA level in bik1 is not the cause of reduced PTI defenses in this mutant, for the reasons below. It was reported that PAMPs induce SA accumulation, and that SA is required for the expression of a portion of PAMP-response genes (Tsuda et al., 2008) . This is consistent with our findings that the sid2 mutant showed reduced callose deposition and oxidative burst in response to flg22 treatment ( Figures S6A and S6B ). In addition, the ein3/eil1 double mutant constitutively accumulates SA and shows increased callose deposition in response to flg22 . These results clearly demonstrate a positive role of SA in PTI defenses. Indeed, introduction of the sid2 mutation into bik1 did not restore PTI defenses to bik1. Importantly, flg22-induced resistance to P. syringae bacteria was intact in the sid2 mutant but abolished in the bik1/sid2 double mutant ( Figure S6C ). Together, these results indicate that the reduction of PTI signaling in bik1 was unlikely to be caused by the elevated SA in this mutant. The direct cause of SA accumulation in the bik1 mutant is not known, but it is not uncommon that positive regulators of plant immunity also act to feedback inhibit SA biosynthesis. For instance, WRKY54 and WRKY70 positively regulate SA-response gene expression but also negatively regulate SA accumulation (Wang et al., 2006) . Likewise, BAK1 is a positive regulator critically important for PTI signaling, but the bak1/bkk1 double mutant exhibits SAdependent cell death . It was recently shown that another receptor-like kinase, BIR1, interacts with BAK1 to negatively regulate cell death and SA accumulation (Gao et al., 2009) . It may be that BIK1 also mediates BIR1-dependent SA regulation in addition to PAMP signaling.
BIK1 directly interacts with FLS2 in unstimulated plant cells and is phosphorylated upon stimulation by flg22 in an FLS2-dependent manner. Similarly, PBL1 also interacts with unstimulated FLS2 and is phosphorylated upon flg22 stimulation. AvrPto, which inhibits FLS2 kinase activity, blocks flg22-induced BIK1 phosphorylation and BIK1-FLS2 dissociation. The flg22-induced BAK1-FLS2 association is not affected by the ATPbinding site mutant form of BIK1, which does not dissociate from FLS2. In contrast, the flg22-induced phosphorylation of BIK1 and BIK1-FLS2 dissociation requires BAK1. Together, these results support the proposal that BIK1 acts downstream of FLS2 and BAK1. ATP-binding site and phosphorylation site mutant forms of BIK1 dominantly inhibit PTI defenses, indicating that the activated BIK1 kinase positively regulates PTI signaling. The flg22-induced phosphorylation of BIK1 and PBL1 and their dissociation from FLS2 are reminiscent of the ligand-induced BSK1 phosphorylation and dissociation from BRI1 in the brassinosteroid signaling pathway . It is possible that the dissociation of the phosphorylated BIK1 and PBL1 proteins from FLS2 allows the activation of other components downstream of BIK1 and PBL1.
Following the submission of this work, Lu et al. (2010) reported a flg22-induced phosphorylation of BIK1 which is largely consistent with our findings. By using co-IP assays in protoplasts, this work suggested that BIK1 can interact with FLS2 and BAK1. The BIK1-FLS2 interaction is consistent with our findings. Our co-IP assays showed a BIK1-BAK1 association only when FLS2 or EFR was overexpressed in the same protoplasts, suggesting that this association is indirect, at least in our analysis.
Our findings that AvrPphB targets the closely related kinases BIK1, PBL1, PBL2, and PBS1 provide insight into the evolution of RPS5-specified ETI. The pbs1 mutant displayed marginal defects in PTI defenses. Unlike the bik1 mutant, pbs1 was not compromised in PAMP-induced resistance to P. syringae. The data are consistent with two models. In the first scenario, BIK1, PBL1, PBL2, and PBS1 are functionally additive, as suggested by the enhanced defects in PTI defenses in the bik1/pbl1 double mutant. PBS1 may be an operational virulence target (van der Hoorn and Kamoun, 2008) that has evolved into a molecular sensor of AvrPphB (Dangl and Jones, 2001) . The association of PBS1 with RPS5 allows the latter to trigger ETI upon sensing the cleavage-induced conformational change in PBS1 (Ade et al., 2007) . Alternatively, PBS1 might have evolved from an ancestral protein that once was an important PTI signaling component, a possibility consistent with the normal PAMP-induced resistance to P. syringae in pbs1. The minor reduction of PTI defenses in pbs1 may reflect residue activity of PBS1 in PTI signaling. In this scenario, PBS1 may act as a ''decoy'' by mimicking true virulence targets, such as BIK1, to trigger ETI . Although further study is needed to test these models, our results strongly support the notion that ETI has evolved to detect the virulence activity of pathogen effectors.
EXPERIMENTAL PROCEDURES Plant Materials
Arabidopsis thaliana plants used in this study include the WT (Col-0) and rps5-2 (Warren et al., 1998) , bik1 (Veronese et al., 2006) , pbs1-2 (Warren et al., 1999) , cerk1 (Wan et al., 2008) , fls2 (Xiang et al., 2008) , efr (Zipfel et al., 2006) , and pbl1 and pbl2 ( Figure S5F ) mutants. BIK1::BIK1-HA, PBL1::PBL1-HA, and estradiol-inducible AvrPphB-FLAG, BIK1-FLAG (BIK1OX), and BIK1 K105E -FLAG (K105EOX) transgenic plants were generated as described in Supplemental Information.
Transient Expression and Reporter Assay in Protoplasts
Protoplasts isolated from 5-week-old plants were cotransfected with FRK1::LUC and 35S::RLUC (Renilla luciferase) along with the indicated constructs. Twelve hours after transfection, protoplasts were treated with 1 mM flg22 or 1 mM elf18 or 200 mg/ml chitin. Protein was isolated 3 hr after PAMP treatment, and LUC activity was determined by using the Dual-Luciferase Reporter system (Promega) following the manufacturer's instructions.
Oxidative Burst
Five-week-old plant leaves were sliced into approximately 1 mm strips, incubated in H 2 O in a 96-well plate for 12 hr, and treated with 1 mM flg22, 1 mM elf18, or 200 mg/ml chitin in 100 ml buffer containing 20 mM luminol and 1 mg/ml horseradish peroxidase (Sigma) as described . Luminescence was recorded by using the GLOMAX 96 microplate luminometer (Promega). Each data point consists of at least four replicates. For experiments involving the AvrPphB-FLAG transgene, plants were pretreated with estradiol as described (Li et al., 2005) prior to the oxidative burst assay.
Callose Deposition A seedling-based procedure for callose induction was adapted from Clay et al. (2009) . Briefly, Arabidopsis seeds were germinated in a 12-well tissue-culture plate containing liquid MS medium at 23 C with 75% relative humidity under 16 hr daylight. Seedlings were transferred to fresh media on day 8, and 9-day-old seedlings were treated with H 2 O, 1 mM flg22, 1 mM elf18, or 200 mg/ml chitin for 18 hr. Callose staining, image acquisition, and processing were carried out as described . Each data point consists of five replicates.
Bacterial Growth Assay
For the flg22-protection assay, 5-week-old plants were first infiltrated with 1 mM flg22 or H 2 O 1 day before infiltrating 10 6 cfu/ml P. syringae DC3000.
Leaf bacterial number was determined at the indicated times after bacterial inoculation. Each data point consists of at least four replicates. For spray inoculation, plants were sprayed with an hrcC À mutant derived from DC3000 (Yuan and He, 1996) at 5 3 10 8 cfu/ml, and bacterial population in the leaf was determined at the indicated times.
GST Pull-Down Assay GST or GST-BIK1 was expressed in Escherichia coli. Soluble protein was passed through a glutathione agarose column, washed five times with washing buffer (25 mM Tris-HCl [pH 7.5], 50 mM NaCl, 3 mM DTT). His-tagged FLS2 kinase domain (FLS2KD-His) was expressed in E. coli and purified by using an Ni-NTA column (Xiang et al., 2008) . Equal amounts of purified FLS2KD-His were passed through a glutathione agarose column containing GST or GST-BIK1. The column was washed five times with washing buffer as above, and the bound protein was eluted with elution buffer (15 mM GSH, 25 mM Tris-HCl [pH 7.5], 50 mM NaCl, 3 mM DTT). The presence of FLS2KD-His was detected by an anti-His immunoblot.
Coimmunoprecipitation Assay
Total protein was extracted from 10-day-old rps5, rps5/BIK1::BIK1-HA, or rps5/PBL1::PBL1-HA transgenic plants (T2 generation) with extraction buffer (50 mM HEPES [pH 7.5], 150 mM KCl, 1 mM EDTA, 1 mM DTT, 0.2% Triton X-100, 1 mM PMSF). For anti-HA IP, total protein was precleared with protein A agarose (Upstate) for 1 hr, followed by precipitation with 2 mg anti-HA together with protein A agarose for 4 hr. For anti-FLAG IP, total protein was incubated with an agarose-conjugated anti-FLAG antibody for 4 hr. Immunoprecipitates were separated by 10% NuPAGE gel (Invitrogen), and the presence of FLS2, BIK1-HA, or PBL1-HA was detected by anti-FLS2 and anti-HA immunoblot. For co-IP experiments in protoplasts, the protoplasts were incubated for 12 hr after transfection, treated with either H 2 O or 1 mM flg22 for 5-10 min, and total protein was extracted for co-IP. The presence of PBL-HA, PBS1-HA, BAK1-FLAG, FLS2-FLAG, EFR-FLAG, or CERK1-FLAG was detected by anti-HA and anti-FLAG immunoblot.
Detection of BIK1 and PBL1 Phosphorylation WT or fls2 protoplasts were transfected with BIK1-HA or PBL1-HA alone or together with FLS2-FLAG. The protoplasts were then treated with 1 mM flg22, and total protein was extracted at various time points with a buffer containing 50 mM HEPES (pH 7.5), 0.15 M NaCl, 1 mM EDTA, 5 mM sodium fluoride, 1 mM sodium vanadate, 1 mM DTT, 0.1% Triton X-100, and 13 proteinase inhibitor cocktail (Roche). Samples were separated by 10% NuPAGE gel (Invitrogen) and subjected to anti-HA immunoblot. For phosphatase treatment, total protein was treated with l protein phosphatase (New England Biolabs) according to the manufacturer's instructions.
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